Physical Activity Intervention for Improving Vascular Comorbidity Risk in Multiple Sclerosis

Stopped earlyNot a drug-phase studyMS (type not specified)NCT03944538

What it found

Stopped

The trial ended early for another reason (see below).

Reason given: Research restrictions and recruitment challenges due to the COVID-19 pandemic

This trial finished 6 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Lifestyle Physical Activity

Compared with

  • General Wellness

What it measured

Main measures

  • Change in Cardiorespiratory Fitness

    Change in cardiorespiratory fitness from baseline at 6- and 12-months

    Physical function

Other measures (5)

  • Change in Blood Pressure

    Change in blood pressure from baseline at 6- and 12-months

  • Change in Body Composition

    Change in body composition from baseline at 6- and 12-months

    Physical function
  • Change in Blood Glucose

    Change in blood glucose from baseline at 6- and 12-months

  • Change in Insulin Resistance

    Change in insulin resistance from baseline at 6- and 12-months

  • Change in Triglycerides and Cholesterols

    Change in triglycerides and cholesterols from baseline at 6- and 12-months

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* Diagnosis of multiple sclerosis * Relapse-free in the past 30 days * Stable course of disease modifying therapy over the past 6 months * Being non-active, defined as not engaging in regular exercise (i.e., ≥30 minutes/day on >2 days/week during the last 6 months) * Internet access * Ability to comprehend study materials and communicate in English * Expanded Disability Status Scale (EDSS) score \<6.0 * Willingness to complete three testing sessions at the University of Ottawa separated by 6 months * Willing to undergo randomization to a lifestyle physical activity condition or general wellness condition for 6 months * Intermediate risk level for cardiovascular disease based on the Framingham Cardiovascular Disease Risk Score calculator * Asymptomatic (i.e., no major signs or symptoms of acute or uncontrolled cardiovascular, metabolic, or renal disease; e.g., chest pain) based on the Get Active Questionnaire and the health history section of the American Heart Association (AHA)/American College of Sports Medicine (ACSM) Health/Fitness Facility Pre-participation Screening Questionnaire * Physician approval for participation

Exclusion criteria

* Pregnancy * Previous enrollment in lifestyle physical activity behaviour interventions

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Vascular comorbidities, such as high cholesterol, obesity, high blood pressure, and diabetes, are common among people with multiple sclerosis (MS), and can negatively impact disease diagnosis, treatment, and progression. Physical inactivity may be one possible reason for this increased risk and may occur through changes in cardiorespiratory fitness (the ability of the body to transport and use oxygen during sustained physical activity). While exercise training is effective for improving fitness, factors such as accessibility to facilities and financial cost may not make it a viable option for most people with MS. An alternative approach for improving fitness is by increasing daily physical activity levels. The research team has developed and tested an Internet-delivered lifestyle physical activity intervention that has been shown to improve physical activity levels among people with MS. This lifestyle intervention is a promising approach for also increasing fitness and managing vascular comorbidity risk in persons with MS. This randomized clinical trial will examine the efficacy of a 6-month lifestyle physical activity intervention on cardiorespiratory fitness and vascular comorbidity risk in persons with MS.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jul 2019

    2. Main results due

      Oct 2020

    3. Finished

      Oct 2020

    Assembled by software from public sources.